CD36 and obesity disorder: Control or CD36 peptide treatment was conducted in male C57BL6 mice after 14 weeks of high fat diet feeding when these mice developed obesity, chronic inflammation, and insulin resistance as compared to low fat feeding (LF) groups (Supplemental Fig. 1).